PB-203

N/A

Report date: 2024/11/15 10:00:09

Base Information

Drug NamePB-203
Drug Alias NamePB-203PB203
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionVascular endothelial growth factor inhibitorsPlacental Growth Factor inhibitorsProgrammed death-ligand 1 blockers
TargetsProgrammed death-ligand 1Vascular endothelial growth factorPlacental Growth Factor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPanolos Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesPanolos Bioscience Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A